Long-Term Outcomes of Patients With CML Without a Major Molecular Response After 2 Years of TKI Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chronic myeloid leukemia without major molecular response after 2 years of treatment with tyrosine kinase inhibitor
Am. J. Hematol 2023 Jan 06;[EPub Ahead of Print], A Bidikian, E Jabbour, GC Issa, NJ Short, K Sasaki, H KantarjianFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.